Cargando…

Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study

BACKGROUND: Young-onset breast cancer (<40 years) is associated with worse prognosis and higher mortality. Breast cancer risk factors may contribute to distinct tumor biology and distinct age at onset, but understanding of these relationships has been hampered by limited representation of young w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chollet-Hinton, Lynn, Anders, Carey K., Tse, Chiu-Kit, Bell, Mary Beth, Yang, Yang Claire, Carey, Lisa A., Olshan, Andrew F., Troester, Melissa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972943/
https://www.ncbi.nlm.nih.gov/pubmed/27492244
http://dx.doi.org/10.1186/s13058-016-0736-y
_version_ 1782446323714228224
author Chollet-Hinton, Lynn
Anders, Carey K.
Tse, Chiu-Kit
Bell, Mary Beth
Yang, Yang Claire
Carey, Lisa A.
Olshan, Andrew F.
Troester, Melissa A.
author_facet Chollet-Hinton, Lynn
Anders, Carey K.
Tse, Chiu-Kit
Bell, Mary Beth
Yang, Yang Claire
Carey, Lisa A.
Olshan, Andrew F.
Troester, Melissa A.
author_sort Chollet-Hinton, Lynn
collection PubMed
description BACKGROUND: Young-onset breast cancer (<40 years) is associated with worse prognosis and higher mortality. Breast cancer risk factors may contribute to distinct tumor biology and distinct age at onset, but understanding of these relationships has been hampered by limited representation of young women in epidemiologic studies and may be confounded by menopausal status. METHODS: We examined tumor characteristics and epidemiologic risk factors associated with premenopausal women’s and young women’s breast cancer in phases I–III of the Carolina Breast Cancer Study (5309 cases, 2022 control subjects). Unconditional logistic regression was used to assess heterogeneity by age (<40 vs. ≥40 years) and menopausal status. RESULTS: In both premenopausal and postmenopausal strata, younger women had more aggressive disease, including higher stage, hormone receptor-negative, disease as well as increased frequency of basal-like subtypes, lymph node positivity, and larger tumors. Higher waist-to-hip ratio was associated with reduced breast cancer risk among young women but with elevated risk among older women. Parity was associated with increased risk among young women and reduced risk among older women, while breastfeeding was more strongly protective for young women. Longer time since last birth was protective for older women but not for young women. In comparison, when we stratified by age, menopausal status was not associated with distinct risk factor or tumor characteristic profiles, except for progesterone receptor status, which was more commonly positive among premenopausal women. CONCLUSIONS: Age is a key predictor of breast cancer biologic and etiologic heterogeneity and may be a stronger determinant of heterogeneity than menopausal status. Young women’s breast cancer appears to be etiologically and biologically distinct from that among older women. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-016-0736-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4972943
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49729432016-08-05 Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study Chollet-Hinton, Lynn Anders, Carey K. Tse, Chiu-Kit Bell, Mary Beth Yang, Yang Claire Carey, Lisa A. Olshan, Andrew F. Troester, Melissa A. Breast Cancer Res Research Article BACKGROUND: Young-onset breast cancer (<40 years) is associated with worse prognosis and higher mortality. Breast cancer risk factors may contribute to distinct tumor biology and distinct age at onset, but understanding of these relationships has been hampered by limited representation of young women in epidemiologic studies and may be confounded by menopausal status. METHODS: We examined tumor characteristics and epidemiologic risk factors associated with premenopausal women’s and young women’s breast cancer in phases I–III of the Carolina Breast Cancer Study (5309 cases, 2022 control subjects). Unconditional logistic regression was used to assess heterogeneity by age (<40 vs. ≥40 years) and menopausal status. RESULTS: In both premenopausal and postmenopausal strata, younger women had more aggressive disease, including higher stage, hormone receptor-negative, disease as well as increased frequency of basal-like subtypes, lymph node positivity, and larger tumors. Higher waist-to-hip ratio was associated with reduced breast cancer risk among young women but with elevated risk among older women. Parity was associated with increased risk among young women and reduced risk among older women, while breastfeeding was more strongly protective for young women. Longer time since last birth was protective for older women but not for young women. In comparison, when we stratified by age, menopausal status was not associated with distinct risk factor or tumor characteristic profiles, except for progesterone receptor status, which was more commonly positive among premenopausal women. CONCLUSIONS: Age is a key predictor of breast cancer biologic and etiologic heterogeneity and may be a stronger determinant of heterogeneity than menopausal status. Young women’s breast cancer appears to be etiologically and biologically distinct from that among older women. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-016-0736-y) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-04 2016 /pmc/articles/PMC4972943/ /pubmed/27492244 http://dx.doi.org/10.1186/s13058-016-0736-y Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chollet-Hinton, Lynn
Anders, Carey K.
Tse, Chiu-Kit
Bell, Mary Beth
Yang, Yang Claire
Carey, Lisa A.
Olshan, Andrew F.
Troester, Melissa A.
Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title_full Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title_fullStr Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title_full_unstemmed Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title_short Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
title_sort breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the carolina breast cancer study: a case-control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972943/
https://www.ncbi.nlm.nih.gov/pubmed/27492244
http://dx.doi.org/10.1186/s13058-016-0736-y
work_keys_str_mv AT chollethintonlynn breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT anderscareyk breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT tsechiukit breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT bellmarybeth breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT yangyangclaire breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT careylisaa breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT olshanandrewf breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy
AT troestermelissaa breastcancerbiologicandetiologicheterogeneitybyyoungageandmenopausalstatusinthecarolinabreastcancerstudyacasecontrolstudy